Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)
Part of paid clinical trials in Cities in Alabama, Alabama.
- Sponsor
- AstraZeneca
- Study ID
- NCT00062582
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Roflumilast — DRUG
Study Details
The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.
Key Dates
- Start date
- Jun 30, 2003
- Status verified
- Sep 2016
Study Design
- Enrollment
- 1,000 participants
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
pulmonary function.
Locations (32)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ALTANA Pharma | Cities in Alabama | Alabama | - | - |
| ALTANA Pharma | Cities in Arizona | Arizona | - | - |
| ALTANA Pharma | Cities in California | California | - | - |
| ATLANA Pharma | Cities in Colorado | Colorado | - | - |
| ALTANA Pharma | Cities in Conneticut | Connecticut | - | - |
| ALTANA Pharma | Cities in Delaware | Delaware | - | - |
| ALTANA Pharma | Cities in Florida | Florida | - | - |
| ALTANA Pharma | Cities in Georgia | Georgia | - | - |
| ALTANA Pharma | Cities in Idaho | Idaho | - | - |
| ALTANA Pharma | Cities in Indiana | Indiana | - | - |
| ALTANA Pharma | Cities in Iowa | Iowa | - | - |
| ALTANA Pharma | Cities in Kansas | Kansas | - | - |
| ALTANA Pharma | Cities in Kentucky | Kentucky | - | - |
| ALTANA Pharma | Cities in Louisiana | Louisiana | - | - |
| ALTANA Pharma | Cities in Maryland | Maryland | - | - |
| ALTANA Pharma | Cities in Michigan | Michigan | - | - |
| ALTANA Pharma | Cities in Missouri | Missouri | - | - |
| ALTANA Pharma | Cities in Nebraska | Nebraska | - | - |
| ALTANA Pharma | Cities in Nevada | Nevada | - | - |
| ALTANA Pharma | Cities in New Jersey | New Jersey | - | - |
| ALTANA Pharma | Cities in New York | New York | - | - |
| ALTANA Pharma | Cities in North Carolina | North Carolina | - | - |
| ALTANA Pharma | Cities in Ohio | Ohio | - | - |
| ALTANA Pharma | Cities in Oregon | Oregon | - | - |
| ALTANA Pharma | Cities in Pennsylvania | Pennsylvania | - | - |
| ALTANA Pharma | Cities in Rhode Island | Rhode Island | - | - |
| ALTANA Pharma | Cities in South Carolina | South Carolina | - | - |
| ALTANA Pharma | Cities in Texas | Texas | - | - |
| ALTANA Pharma | Cities in Utah | Utah | - | - |
| ALTANA Pharma | Cities in Virginia | Virginia | - | - |
| ALTANA Pharma | Cities in Washington | Washington | - | - |
| ALTANA Pharma | Cities in West Virginia | West Virginia | - | - |
Find similar trials in Cities in Alabama, AL
By condition
By specialty
Related Studies
- Emphysema Research Registry and Biosample RepositoryRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- : Vascular Function in Health and DiseasePHASE1 · Recruiting · Russell Richardson · Salt Lake City, Utah
- Hyper Polarized Xenon-129 MRI vs Xenon-133 ScintigraphyPHASE1/PHASE2 · Recruiting · University of Virginia · Charlottesville, Virginia
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)Recruiting · VA Office of Research and Development · Detroit, Michigan